Work

Pharmacogenetic Analysis of Glutamate System Gene Variants and Clinical Response to Clozapine

Year: 2015
Type: dissertation
Study design: Observational Study
Abstract: Altered glutamatergic neurotransmission is implicated in schizophrenia etiology and response to the atypical antipsychotic clozapine. Response to clozapine is highly variable and partly depends on genetic factors as indicated by twin studies. The association of 17 glutamate system gene variants and clinical response to clozapine was investigated in a sample of European schizophrenia/schizoaffective patients deemed resistant/intolerant to previous pharmacotherapy. Categorical and continuous response measures were assessed following six months of clozapine treatment using change in Brief Psychiatric Rating Scale Scores, and were analyzed using PearsonĂ¢ s chi-squared test or analysis of covariance, respectively. No significant associations were observed for all analyses after correction for multiple testing. Prior to correction, several nominally significant associations were observed, the most notable being between the SLC6A9 rs16831558 variant and change in positive symptoms (puncorrected=0.008, pcorrected=0.08). This finding warrants further investigation in larger well-characterized samples to clarify the role of SLC6A9 in clinical response to clozapine.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W2574104565
Cites: 465
Cited by:
Related to: 10